The rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat small patient populations.
The US government is updating crucial quality ratings for private <-bsp-bb-link state="{"bbHref":"bbg://news/topics/MEDICARE","_id":"00000190-25e0-d5f2-a594-f7e435bb0000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Medicare plans, paving the way for 2025 bonus payments worth hundreds of millions of dollars to insurers that operate health plans for seniors.
The Biden administration is urging a federal judge to shoot down Florida’s request to block a federal transgender health civil rights rule from going into effect, arguing the state is incorrectly framing its requirements.
A law firm set to earn more than $100 million for its work on opioids cases is packaging its fees and selling it to investors as a security.
A US Supreme Court decision maintaining access to the abortion drug mifepristone complicates a debate on how much say the federal government can have in how states regulate reproductive care, attorneys said.
The US Surgeon General on Monday called for adding a formal warning label on social media sites akin to those placed on cigarette cartons, warning parents that TikTok, Instagram and other platforms can harm kids’ mental health.
The government’s new authority is limited to just 10 medicines purchased by Medicare, and manufacturers may charge more for years before negotiations kick in.
The rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat small patient populations.
A law firm set to earn more than $100 million for its work on opioids cases is packaging its fees and selling it to investors as a security.
<-bsp-bb-link state="{"bbHref":"bbg://securities/4502%20JP%20Equity","_id":"00000190-25b9-d5f2-a594-f7bde8280000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Takeda Pharmaceutical Co. signed an option agreement with Chinese drug developer <-bsp-bb-link state="{"bbHref":"bbg://securities/6855%20HK%20Equity","_id":"00000190-25b9-d5f2-a594-f7bde8280001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Ascentage Pharma Group International for the development of a blood-cancer drug, as the Japanese drug maker attempts to revive its drug pipeline and boost growth.
Five
A former Cook County, Ill., pharmacist can pursue her claims she was fired in retaliation for speaking out against policies regarding the administration of narcotics to prisoners, an Illinois appellate court ruled Friday.
A
When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.
The US Surgeon General on Monday called for adding a formal warning label on social media sites akin to those placed on cigarette cartons, warning parents that TikTok, Instagram and other platforms can harm kids’ mental health.
Welcome to Bloomberg Law’s Wake Up Call, a daily rundown of the top news for lawyers, law firms, and in-house counsel.
The US Labor Department’s newly amended exemption to federal benefits law allowing asset managers to oversee workplace retirement funds imposes stricter disclosure and recordkeeping requirements that will prompt some Wall Street firms to weigh alternatives.
A law firm set to earn more than $100 million for its work on opioids cases is packaging its fees and selling it to investors as a security.
Environmental lawyers are attempting to form the first known union of litigating attorneys in Justice Department history, a campaign sparked by return-to-office mandates and fears of political intervention, employee and labor organizers said.
JD-Next’s David Klieger recommends steps for law schools to further diversify admissions since the US Supreme Court’s decision killing affirmative action.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas:
